Answers are grounded in this paper and cite their sources.
We isolated testosterone-estradiol-binding globulin (TeBG) from human pregnancy plasma and used the isolated protein to obtain a rabbit antiserum to it. Using immunochemical techniques, the antiserum was demonstrated to be both monospecific and to have the ability to remove TeBG-binding activity from human serum. This antiserum was used to develop a RIA for human TeBG. The sensitivity is such that TeBG can be determined in as little as 0.005 microliter serum or plasma, although we routinely use 0.5-1.0 microliter. The correlation between the RIA and an established binding assay, using 63 different specimens, was 0.995.
No takes yet. Share an insight, caveat, or question.
Khan et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: